Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M279,046Revenue $M70,074Net Margin (%)22.0Altman Z-Score5.0
Enterprise Value $M261,490EPS $5.2Operating Margin %26.1Piotroski F-Score4
P/E(ttm)19.2Beneish M-Score-2.8Pre-tax Margin (%)27.4Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %4.3Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %3.5Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow19.0y-y EBITDA Growth Rate %-18.2ROA % (ttm)14.1Higher Current Ratio y-yN
Dividend Yield %2.9PEG5.5ROE % (ttm)25.9Less Shares Outstanding y-yY
Payout Ratio %56.0Shares Outstanding M2,767ROIC % (ttm)31.4Gross Margin Increase y-yN

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJTweedy Browne 2015-12-31 Reduce-0.45%$93.42 - $105.25
($100.75)
$ 100.850%Reduce -4.22%3,693,349
JNJYacktman Focused Fund 2015-12-31 Reduce-0.17%$93.42 - $105.25
($100.68)
$ 100.850%Reduce -3.85%2,500,000
JNJDonald Yacktman 2015-12-31 Reduce-0.15%$93.42 - $105.25
($100.75)
$ 100.850%Reduce -3.23%7,316,129
JNJCharles Brandes 2015-12-31 Add0.05%$93.42 - $105.25
($100.75)
$ 100.850%Add 27.50%151,094
JNJKen Fisher 2015-12-31 Add0.03%$93.42 - $105.25
($100.68)
$ 100.850%Add 1.18%10,815,964
JNJMario Gabelli 2015-12-31 Add0.01%$93.42 - $105.25
($100.75)
$ 100.850%Add 4.54%332,287
JNJJames Barrow 2015-12-31 Reduce-0.01%$93.42 - $105.25
($100.75)
$ 100.850%Reduce -0.38%15,342,046
JNJRichard Pzena 2015-12-31 Add$93.42 - $105.25
($100.75)
$ 100.850%Add 0.03%1,174,524
JNJYacktman Focused Fund 2015-09-30 Add0.17%$90.73 - $101.11
($96.79)
$ 100.854%Add 4.00%2,600,000
JNJTweedy Browne 2015-09-30 Reduce-0.17%$90.73 - $101.11
($96.79)
$ 100.854%Reduce -1.60%3,855,936
JNJCharles Brandes 2015-09-30 Buy 0.16%$90.73 - $101.11
($96.79)
$ 100.854%New holding118,509
JNJJohn Rogers 2015-09-30 Add0.12%$90.73 - $101.11
($96.79)
$ 100.854%Add 13.06%884,154
JNJYacktman Fund 2015-09-30 Add0.12%$90.73 - $101.11
($96.79)
$ 100.854%Add 2.86%3,600,000
JNJDonald Yacktman 2015-09-30 Add0.07%$90.73 - $101.11
($96.79)
$ 100.854%Add 1.59%7,560,334
JNJDavid Dreman 2015-09-30 Sold Out -0.05%$90.73 - $101.11
($96.79)
$ 100.854%Sold Out0
JNJJames Barrow 2015-09-30 Reduce-0.03%$90.73 - $101.11
($96.79)
$ 100.854%Reduce -1.49%15,399,839
JNJTom Gayner 2015-09-30 Add0.02%$90.73 - $101.11
($96.79)
$ 100.854%Add 1.39%582,200
JNJT Rowe Price Equity Income Fund 2015-09-30 Add0.02%$90.73 - $101.11
($96.79)
$ 100.854%Add 0.86%4,672,800
JNJKen Fisher 2015-09-30 Add0.01%$90.73 - $101.11
($96.79)
$ 100.854%Add 0.45%10,689,483
JNJFirst Eagle Investment 2015-09-30 Reduce-0.01%$90.73 - $101.11
($96.79)
$ 100.854%Reduce -1.50%1,585,928
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fasolo PeterVP, Global Human Resources 2016-02-03Sell151,385$104.12-2.3view
Ullmann Michael HVP, General Counsel 2015-11-20Sell17,650$102.47-0.72view
Caruso Dominic JVP, Finance; CFO 2015-11-02Sell20,569$102.21-0.47view
Kapusta Ronald AController, CAO 2015-10-23Sell6,239$99.682.06view
PRINCE CHARLESDirector 2015-08-06Buy2,500$99.252.5view
PRINCE CHARLESDirector 2015-06-02Buy2,500$99.222.53view
Stoffels PaulusChief Scientific Officer 2015-04-28Sell187,250$100.730.99view
Fasolo PeterVP, Global Human Resources 2015-03-05Sell115,307$102.4-0.65view
COSGROVE STEPHEN JCorporate Controller 2014-11-05Sell2,490$108.55-6.28view
Ullmann Michael HVP, General Counsel 2014-10-31Sell17,350$107.43-5.31view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Consider This Market with Negligible Volatility and Consistently Rising Values Feb 05 2016 
    Valeant's Share Price Continues to Decline Feb 05 2016 
    Johnson & Johnson: Dividend Aristocrats Part 50 Jan 27 2016 
    Three Stock Picks for 2016 Jan 15 2016 
    Investment Ideas Trading With Very Low P/S Ratio Jan 13 2016 
    Why Dividend Growth Investing Should Be Your New Year’s Resolution Jan 03 2016 
    Dividend Aristocrats Part 39: Kimberly-Clark Dec 30 2015 
    5 Guru Picks in Volatile Biotech Industry Dec 23 2015 
    Analyzing Amgen's Dividend Hike Dec 20 2015 
    Mairs and Power Buys American Express, Pfizer in 3rd Quarter Dec 10 2015 

    More From Other Websites
    Johnson & Johnson (JNJ) Stock Closed Down, Pfizer Developing Biosimilar Feb 10 2016
    Why Pfizer (PFE) Stock Is Rising Today Feb 10 2016
    Panel Recommends FDA Approval of Remicade Knockoff Feb 10 2016
    The Generic Drug Battle Feb 10 2016
    U.S. Futures Tick Higher as Janet Yellen Worries Over Economy Feb 10 2016
    Johnson & Johnson Gets Extrapolated Feb 10 2016
    Early movers: TWX, DIS, DB, SPLS, CNX, P & more Feb 10 2016
    Johnson & Johnson’s Imbruvica Sees Increased Sales in 4Q15 Feb 10 2016
    JNJ’s Pharmaceutical Segment Contributes 45.3% of Revenue in 4Q15 Feb 10 2016
    Panel Recommends FDA Approval of Remicade Knockoff Feb 10 2016
    FDA panel backs lower-cost version of J&J's top-selling drug Feb 09 2016
    Harvard-based weight loss startup combines tech, human coach Feb 09 2016
    Pfizer, Reynolds Among Recession Stock Plays — GE, GM For Recovery Feb 09 2016
    Tweedy Browne Reopens Global Value Fund II Feb 09 2016
    Icahn, Gilead, GE Lead Top Insider Trades Of The Week Feb 09 2016
    Local Johnson & Johnson move affects 127 employees Feb 09 2016
    What Investors Can Expect from Healthcare Sector Companies Feb 09 2016
    Johnson & Johnson to Participate in RBC Capital Markets Global Healthcare Conference Feb 09 2016
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK